Mechanisms of doping with erythropoietin;Wirkungsmechanismen von erythropoetindoping

Deutsche Zeitschrift fur Sportmedizin

Volumn 59, Issue 7-8, 2008, Pages 175-177

  Böning, Dieter ^a   Maassen, N ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Blood doping; Erythrocytes; Optimal hematocrit; Placebo

Indexed keywords

EID: 50149106075     PISSN: 03445925     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. AGARWAL R: Nonhematological benefits of iron. Am J Nephrol 27 (2007) 565-571.
2. ALTMAN PL, DITTMER DS: Biology Data Book. Washington, D. C.: Federation of American Societies for Experimental Biology, 1964.
3. ASHENDEN MJ, GORE CJ, PARISOTTO R, SHARPE K, HOPKINS WG, HAHN AG: Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 88 (2003) 1053-1062.
4. AUDRAN M, GAREAU R, MATECKI S, DURAND F, CHENARD C, SICART M-T, MARION B, BRESSOLLE F: Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc 31 (1999) 639-645.
5. BEEDIE CJ, COLEMAN DA, FOAD AJ: Positive and negative placebo effects resulting from the deceptive administration of an ergogenic aid. Int J Sport Nutr Exerc Metab 17 (2007) 259-269.
6. BENEDETTI F, POLLO A, COLLOCA L: Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions? J Neurosci 27 (2007) 11934-11939.
7. BIRKELAND KI, STRAY-GUNDERSEN J, HEMMERSBACH P, HALLEN J, HAUG E, BAHR R: Effect of thEPO administration on serum levels of sTfR and cycling performance. Med Sci Sport Exer 32 (2000) 1238-1243.
8. BÖNING D: Höhentraining - was ist gesichert? Dtsch Z Sportmed 47 (1996) 196-200.
9. BÖNING D: Menschliche Lamas? Dtsch Z Sportmed 55 (2004) 268-269.
10. BÖNING D, CRISTANCHO E, SERRATO M, REYES O, MORA M, COY L, ROJAS J: Hemoglobin mass and peak oxygen uptake in untrained and trained female altitude residents. Int J Sports Med 25 (2004) 1-8.
11. CHATTOPADHYAY A, CHOUDHURY TD, B ANDYOPADHYAY D, DATTA AG: Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 59 (2000) 419-425.
12. DANE DM, HSIA CC, WU EY, HOGG RT, HOGG DC, ESTRERA AS, JOHNSON RL, JR: Splenectomy impairs diffusive oxygen transport in the lung of dogs. J Appl Physiol 101 (2006) 289-297.
13. DEMPSEY JA, WAGNER PD: Exercise-induced arterial hypoxemia. J Appl Physiol 87 (1999) 1997-2006.
14. EKBLOM B: Blood boosting and sport. Bailliere's Clinical Endocrinology and Metabolism 14 (2000) 89-98.
15. GAEHTGENS P, KREUTZ F, ALBRECHT KH: Optimal hematocrit for canine skeletal muscle during rhythmic isotonic exercise. Eur J Appl Physiol 41 (1979) 27-39.
16. HEESCHEN C, AICHER A, LEHMANN R, FICHTLSCHERER S, VASA M, URBICH C, MILDNER-RIHM C, MARTIN H, ZEIHER AM, DIMMELER S: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346.
17. LUNDBY C, THOMSEN JJ, BOUSHEL R, KOSKOLOU M, WARBERG J, CALBET JA, ROBACH P: Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume. J Physiol 578 (2007) 309-314.
18. MISKOWIAK K, INKSTER B, SELVARAJ S, WISE R, GOODWIN GM, HARMER CJ: Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology 33 (2008) 611-618.
19. PROMMER N, EHRMANN U, SCHMIDT W, STEINACKER JM, RADERMACHER P, MUTH CM: Total haemoglobin mass and spleen contraction: a study on competitive apnea divers, non-diving athletes and untrained control subjects. Eur J Appl Physiol 101 (2007) 753-759.
20. RENTSCH RL, DAMSGAARD R, LUNDBY C, JUEL C: Effects of darbepoetin injections on erythrocyte membrane transport protein expressions in humans. J Appl Physiol 101 (2006) 164-168.
21. RUSSEL G, GORE CJ, ASHENDEN MJ, PARISOTTO R, HAHN AG: Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal erxercise. Eur J Appl Physiol 86 (2002) 442-449.
22. SCHMIDT W, BÖNING D, BRAUMANN KM: Red cell age effects on metabolism and oxygen affinity in humans. Respir Physiol 68 (1987) 215-225.
23. SCHMIDT W: Screening der totalen Hämoglobinmenge bei Triathleten und professionellen Radrennfahrern. Dtsch Z Sportmed 59 (2008) 146-152.
24. SCHMIDT W, MAASSEN N, TROST F, BÖNING D: Training induced effects on blood volume, erythrocyte turnover and haemoglobin oxygen binding properties. Eur J Appl Physiol 57 (1988) 490-498.
25. SCHMIDT W, PROMMER N, STEINACKER JM, BÖNING D: Sinn und Unsinn von hämatologischen Grenzwerten im Ausdauersport - Folgerungen aus den Dopingskandalen von Turin 2006. Dtsch Z Sportmed 57 (2006) 54-56.
26. THOMSEN JJ, RENTSCH RL, ROBACH P, CALBET JA, BOUSHEL R, RASMUSSEN P, JUEL C, LUNDBY C: Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity. Eur J Appl Physiol 101 (2007) 481-486.
27. 2 uptake kinetics during exercise in humans. J Physiol 568 (2005) 639-652.
28. WU EY, RAMANATHAN M, HSIA CCW: Role of hematocrit in the recruitment of pulmonary diffusing capacity: comparison of human and dog. J Appl Physiol 80 (1996) 1014-1020.